Patent · US Active

Predicting cancer outcome

US8338109B2 · kind B2 · utility

19Cited by

3References

3Claims

0Family size

Assignee

Mayo Foundation for Medical Education and Research · US

Inventors

George Vasmatzis · Byron, US
John C. Cheville · Pine Island, US
Farhad Kosari · Ellsworth, US
Cemile Dilara Savci Heijink · Amsterdam, NL
Jan-Marie Willard Munz · Oronoco, US
Eric W. Klee · Rochester, US
Lori S. Tillmans · Stanton, US

Key dates

Filing date	Nov 2, 2007
Grant date	Dec 25, 2012
Priority date	—
Expiry date	Feb 12, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

This document provides methods and materials related to assessing prostate cancer in mammals. For example, this document provides nucleic acids and polypeptides that can be analyzed to determine whether a male mammal having prostate cancer is susceptible to a good or poor outcome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.